Bio-Works Technologies AB (publ)

Stockholm Stock Exchange BIOWKS.ST

Bio-Works Technologies AB (publ) EBITDA Margin for the year ending December 31, 2023: -124.85%

Bio-Works Technologies AB (publ) EBITDA Margin is -124.85% for the year ending December 31, 2023, a -11.91% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Bio-Works Technologies AB (publ) EBITDA Margin for the year ending December 31, 2022 was -111.57%, a -133.51% change year over year.
  • Bio-Works Technologies AB (publ) EBITDA Margin for the year ending December 31, 2021 was -47.78%, a 92.33% change year over year.
  • Bio-Works Technologies AB (publ) EBITDA Margin for the year ending December 31, 2020 was -622.73%, a 14.87% change year over year.
  • Bio-Works Technologies AB (publ) EBITDA Margin for the year ending December 31, 2019 was -731.49%, a -54.77% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: BIOWKS.ST

Bio-Works Technologies AB (publ)

CEO Ms. Lone Carlbom
IPO Date Dec. 14, 2017
Location Sweden
Headquarters Virdings allé 18
Employees 35
Sector Materials
Industries
Description

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Similar companies

CRAD-B.ST

C-Rad AB (publ)

USD 2.87

-1.57%

GENO.ST

Genovis AB (publ.)

USD 2.25

-17.68%

IVACC.ST

Intervacc AB (publ)

USD 0.09

11.18%

CANTA.ST

Cantargia AB (publ)

USD 0.16

-4.29%

StockViz Staff

February 5, 2025

Any question? Send us an email